Pontifax (China) IV L.P. - Insider Non-Derivative Transactions at Keros Therapeutics, Inc. (KROS) - (SEC)
Updated on March 12, 2026.
According to recent SEC insider information filed on Oct 15, 2025, Pontifax (China) IV L.P.'s relationship to Keros Therapeutics, Inc. (KROS) is TenPercentOwner, and currently has 0 shares of Common Stock, $0.0001 par value per share.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other KROS insiders.
Related Topics: SEC Topic List.
Data Source: SEC.
Pontifax (China) IV L.P. - Insider Non-Derivative Transactions at KROS
Items per page:
25
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Oct 16, 2025 | Sell -- (Common Stock, $0.0001 par value per share) | 2284612 | 17.75 | 0 |
| Oct 16, 2025 | Sell -- (Common Stock, $0.0001 par value per share) | 155262 | 17.75 | 0 |
| Oct 16, 2025 | Sell -- (Common Stock, $0.0001 par value per share) | 1226412 | 17.75 | 0 |
| Oct 16, 2025 | Sell -- (Common Stock, $0.0001 par value per share) | 1121045 | 17.75 | 0 |
Popular Topics:
Find us
Copyright © Beautify Data LLC. All Rights Reserved.